Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
Astellas, GSK-Hansoh, Daiichi—Fierce Pharma Asia
Astellas will close a stem cell therapy site. GSK is launching multiple phase 3 trials for a Hansoh-partnered ADC. Daiichi is selling its OTC business.
Angus Liu
Apr 17, 2026 9:15am
ViiV Healthcare launches ‘Still Here’ HIV campaign
Apr 13, 2026 8:47am
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
Biogen taps Alteogen for help developing 2 subQ biologics
Mar 25, 2026 10:55am
After Alfasigma licensing deal, Lynavoy picks up FDA nod
Mar 19, 2026 10:55am
GSK used Flovent generic partner to 'game the system': senator
Mar 17, 2026 5:05pm
